IGM Biosciences, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
IGMS on Nasdaq
Industry
Pharmaceutical Preparations
Location
325 E Middlefield Road, Mountain View, CA

Insiders trading volume in the past year

IGM Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jakob Haldor Topsoe Director, 10%+ Owner $121M Sep 30, 2024
Redmile Group, LLC Director, 10%+ Owner $83.1M Sep 30, 2024
Baker Bros. Advisors Lp Director, 10%+ Owner $43.4M +$3.43M +8.57% Sep 30, 2024
Topsoe Holding A/S 10%+ Owner $40.4M Jun 26, 2023
Fred Schwarzer CEO AND PRESIDENT, Director $5.16M -$167K -3.13% Sep 13, 2024
Bruce Keyt Chief Scientific Officer $2.85M -$65K -2.23% Sep 13, 2024
Mary Beth Harler Chief Executive Officer, Director $2.6M -$41.8K -1.59% Dec 16, 2024
Chris H. Takimoto Chief Medical Officer $1.78M -$83.4K -4.47% Sep 13, 2024
William Strohl Director $1.75M Aug 8, 2024
Misbah Tahir Chief Financial Officer $1.4M -$96.3K -6.42% Dec 16, 2024
Daniel ShinYu Chen Chief Medical Officer $769K Jul 1, 2021
Christina Teng Topsoe Director, 10%+ Owner $678K Sep 30, 2024
Lisa Lynn Decker Chief Business Officer $584K -$59.8K -9.3% Dec 16, 2024
M. Kathleen Behrens Director $531K Sep 30, 2024
George Gauthier Chief Commercial Officer $262K Nov 29, 2023
Steven Weber Principal Accounting Officer $237K -$23.1K -8.89% Dec 16, 2024
Michael D. Loberg Director $231K Sep 29, 2023
Michael Lee Director $108K Sep 30, 2024
Elizabeth H.Z. Thompson Director $50.3K Sep 30, 2024
Julie Hambleton Director $28K -$212K -88.3% Jul 25, 2024

Recent Insider Transactions by Companies or Individuals for IGM Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.